This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
PXDN antibody (DZ33984) performs well in IHC, WB and shows reactivity with Human, Mouse, Rat.
- Validated for inter-lot consistency, specificity, and reproducibility
- Committed to quality since 1993
Filter:
IHC analysis of Peroxidasin homolog isoform X1 using anti-Peroxidasin homolog isoform X1 antibody (DZ33984).
Peroxidasin homolog isoform X1 was detected in paraffin-embedded section of human pancrease cancer tissue. Heat mediated antigen retrieval was performed in EDTA buffer (pH8.0, epitope retrieval solution). The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 1μg/ml rabbit anti-Peroxidasin homolog isoform X1 Antibody (DZ33984) overnight at 4°C. Biotinylated goat anti-rabbit IgG was used as secondary antibody and incubated for 30 minutes at 37°C. The tissue section was developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1022) with DAB as the chromogen.
Peroxidasin homolog isoform X1 was detected in paraffin-embedded section of human pancrease cancer tissue. Heat mediated antigen retrieval was performed in EDTA buffer (pH8.0, epitope retrieval solution). The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 1μg/ml rabbit anti-Peroxidasin homolog isoform X1 Antibody (DZ33984) overnight at 4°C. Biotinylated goat anti-rabbit IgG was used as secondary antibody and incubated for 30 minutes at 37°C. The tissue section was developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1022) with DAB as the chromogen.
Bundle Save
Anti-human peroxidasin homolog isoform X1 Antibody
PXDN antibody
| Reactive Species | Host | Application |
|---|---|---|
| Human, Mouse, Rat | Rabbit | IHC, WB |
Tested Applications
PXDN antibody was positively detected by WB in:
human Hela whole cell, human U251 whole cell, rat heart tissue, mouse heart tissue
Suggested blocking solution with 5% non-fat milk or BSA; (*)Recommended protein loading: 20-40 ug per lane
PXDN antibody was positively detected by IHC in:
human pancrease cancer tissue, human renal cancer tissue
Use EDTA pH 8.0 for antigen retrieval; (*) citrate buffer pH 6.0 is an alternative.
Recommend Dilution
Application
Dilution
Species
Western blot
0.5 μg/ml
Hu, Ms, Rat
Immunohistochemistry(Paraffin-embedded Section)
1 μg/ml
Hu
* It is recommended to optimize the amount of this reagent in each experimental system to achieve the best results.
Reactive Data
Filter:
Boster Guarantee:What is this?
WB
IHC
IF
Human
Tested
Tested
Recommend
Rat
Tested
Mouse
Tested
Product Information
Product Name
Anti-human peroxidasin homolog isoform X1 Antibody
View all PXDN Antibodies
View all PXDN Antibodies
Form
Liquid
Uniprot
Gene ID
Storage & Handling
At -20°C for one year, at 4°C for one month. Avoid repeated freezing and thawing.
Host
Rabbit
Contents
Each vial contains 20mM PBS, 50% glycerol, 0.02% NaN3.
Clonality
Polyclonal
Isotype
Rabbit IgG
Calculated Molecular Weight
165.3 kDa
Cite This Product
Anti-human peroxidasin homolog isoform X1 Antibody (Boster Biological Technology, Pleasanton CA, USA, Catalog # DZ33984)
Protocols
Western Blot protocol for PXDN antibody
Immunohistochemistry (IHC) protocol for PXDN antibody
Review
Have you used Anti-human peroxidasin homolog isoform X1 Antibody?
Submit a review and receive $370 in product credits, a $185 Amazon gift card, or our carefully curated gift bundles.
Product Promise
We promise Anti-human peroxidasin homolog isoform X1 Antibody performs excellently in relevant applications for IHC, WB. If it doesn't perform as promised, we will refund the product. Learn more
In stock
Order Product
DZ33984
Buy one primary antibody get one 0.5ml HRP or Biotin secondary antibody for free.
*Sample sizes are prepared on demand and will take extra lead time. (cannot be conjugated)
$470.00
Troubleshooting
Boster Guarantee
Guaranteed product quality
We promise all of our products perform as described in datasheets.
This product is for Research Use Only. Not for use in diagnostic procedures.
Update date:
Oct 13, 2026